A detailed history of State Of Wisconsin Investment Board transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 58,320 shares of IDYA stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,320
Previous 72,767 19.85%
Holding current value
$1.53 Million
Previous $2.55 Million 27.68%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.37 - $43.05 $438,755 - $621,943
-14,447 Reduced 19.85%
58,320 $1.85 Million
Q2 2024

Aug 14, 2024

BUY
$34.37 - $43.46 $580,784 - $734,387
16,898 Added 30.25%
72,767 $2.55 Million
Q1 2024

May 14, 2024

BUY
$34.2 - $47.13 $98,940 - $136,347
2,893 Added 5.46%
55,869 $2.45 Million
Q4 2023

Feb 12, 2024

SELL
$24.59 - $35.83 $273,785 - $398,931
-11,134 Reduced 17.37%
52,976 $1.88 Million
Q3 2023

Nov 14, 2023

BUY
$21.07 - $29.77 $444,577 - $628,147
21,100 Added 49.06%
64,110 $1.73 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $51,893 - $99,388
3,893 Added 9.95%
43,010 $1.01 Million
Q1 2023

May 15, 2023

BUY
$13.49 - $18.72 $20,518 - $28,473
1,521 Added 4.05%
39,117 $537,000
Q4 2022

Feb 14, 2023

BUY
$14.47 - $18.17 $544,014 - $683,119
37,596 New
37,596 $683,000
Q2 2022

Aug 15, 2022

SELL
$8.28 - $13.88 $355,212 - $595,452
-42,900 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$11.18 - $24.02 $59,254 - $127,306
-5,300 Reduced 11.0%
42,900 $480,000
Q4 2021

Feb 11, 2022

BUY
$20.95 - $26.88 $546,795 - $701,568
26,100 Added 118.1%
48,200 $1.14 Million
Q4 2020

Feb 03, 2021

BUY
$12.17 - $17.52 $32,859 - $47,304
2,700 Added 13.92%
22,100 $309,000
Q3 2020

Nov 16, 2020

BUY
$11.22 - $14.46 $217,668 - $280,524
19,400 New
19,400 $244,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.26B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.